825 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Downtrend
Article Searches
Stocks making the biggest moves premarket: MRK, PFE, AAPL, UAA, FB, BA & more https://www.cnbc.com/2018/05/01/stocks-making-the-biggest-moves-premarket-mrk-pfe-aapl-uaa-fb-ba-more.html May 01, 2018 - Names on the move ahead of the open.
Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today https://www.fool.com/investing/2017/09/12/heres-why-advaxis-inc-stock-is-getting-pummeled-to.aspx?source=iedfolrf0000001 Sep 12, 2017 - Despite a lack of particularly damaging news, investors are losing patience with this biotech.
Stocks making the biggest moves premarket: BA, NVDA, MRK, DIS & more https://www.cnbc.com/2018/03/12/stocks-making-the-biggest-moves-premarket-ba-nvda-mrk-dis-more.html Mar 12, 2018 - Names on the move ahead of the open.
The IDO-Inhibitor Race Is On to Improve Cancer Treatment https://www.fool.com/investing/2017/04/13/the-ido-inhibitor-race-is-on-to-improve-cancer-tre.aspx?source=iedfolrf0000001 Apr 13, 2017 - NewLink Genetics and Incyte Corporation's IDO-inhibitors could be the next big advance in cancer treatment.
10 Reasons Merck Could Be the World's Most Perfect Stock https://www.fool.com/investing/2017/04/21/10-reasons-merck-could-be-the-worlds-most-perfect.aspx?source=iedfolrf0000001 Apr 21, 2017 - Merck may be a picture-perfect stock for long-term investors to consider buying.
Bleak Outlook for Big Drug Makers https://www.wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153?mod=rss_markets_main Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
5 Great Things About Merck & Co.'s Q1 Results https://www.fool.com/investing/2017/05/02/5-great-things-about-merck-cos-q1-results.aspx?source=iedfolrf0000001 May 02, 2017 - Merck handily beat expectations with its Q1 results. Here's how the drugmaker did it.
Here Are the Big Pharma Stocks to Own Based on R&D Spending https://www.fool.com/investing/2017/08/27/here-are-the-big-pharma-stocks-to-own-based-on-r-2.aspx?source=iedfolrf0000001 Aug 27, 2017 - Roche, Novartis, Pfizer, Johnson & Johnson, and Merck are investing the heaviest in R&D. That could bode well for these big pharma stocks.
This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier https://www.fool.com/investing/2017/08/29/this-simple-step-can-make-diabetes-patients-health.aspx?source=iedfolrf0000001 Aug 29, 2017 - A study by Express Scripts points to how diabetes patients can avoid ER visits and hospital stays while potentially keeping more money in their pockets.
Better Buy: Merck & Co. Inc. vs. Johnson & Johnson https://www.fool.com/investing/2017/04/19/better-buy-merck-co-inc-vs-johnson-johnson.aspx?source=iedfolrf0000001 Apr 19, 2017 - Does Merck's sizzling-hot cancer drug Keytruda give it a leg up over longtime winner Johnson & Johnson?

Pages: 1234567...83

<Page 2>